Cannon Financial Strategists, Inc. Gilead Sciences, Inc. Transaction History

Cannon Financial Strategists, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Oct 02, 2024	SELL	$57.92 - $72.58 $271,876 - $340,690	-4,694 Closed	0 $0
Q4 2021 Oct 02, 2024	BUY	$64.88 - $73.64 $304,546 - $345,666	4,694 New	4,694 $727 Million
Q3 2021 Oct 02, 2024	SELL	$67.69 - $73.03 $23.5 Million - $25.4 Million	-347,503 Closed	0 $0
Q2 2021 Oct 02, 2024	BUY	$63.47 - $69.35 $22.1 Million - $24.1 Million	347,503 New	347,503 $31.3 Billion

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.